Skip Navigation LinksHome > February 2011 - Volume 11 - Issue 1 > Bacterial biofilms and the pathophysiology of chronic rhinos...
Current Opinion in Allergy & Clinical Immunology:
doi: 10.1097/ACI.0b013e3283423376
Rhinitis, sinusitis and upper airway disease: Edited by Ruby Pawankar and David P. Skoner

Bacterial biofilms and the pathophysiology of chronic rhinosinusitis

Al-Mutairi, Dakheelallah; Kilty, Shaun J

Collapse Box


Purpose of review: To review the evidence for the presence of bacterial biofilms in chronic rhinosinusitis (CRS) and mechanisms by which they may contribute to the chronic inflammation characteristic of this disease. Lastly, to provide an overview of the current and potential future treatments for bacterial biofilms in CRS.

Recent findings: Advances in the techniques for identifying biofilms have confirmed the presence of bacterial biofilms on the sinonasal mucosa of patients with CRS. The impact on mucosal inflammation of the polymicrobial or multiorganism milieu is not yet well understood. Numerous novel topical therapies for the treatment of bacterial biofilms in CRS have been suggested with some demonstrating clinical efficacy. Blocking of quorum sensing represents a potential future therapy for biofilm treatment in CRS and biofilm infection at large.

Summary: Biofilms represent an important influence on the pathophysiology of CRS. Further understanding of biofilm interactions and microbial organism behavior will provide us with future treatment modalities for this disease.

Copyright © 2011 Wolters Kluwer Health, Inc. All rights reserved.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.